Literature DB >> 4332292

Research complications due to Haemobartonella and Eperythrozoon infections in experimental animals.

H J Baker, G H Cassell, J R Lindsey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4332292      PMCID: PMC2047626     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  51 in total

1.  COMPARISON OF A LACTATE DEHYDROGENASE ELEVATING VIRUSLIKE AGENT AND EPERYTHROZOON COCCOIDES.

Authors:  V RILEY; J D LOVELESS; M A FITZMAURICE
Journal:  Proc Soc Exp Biol Med       Date:  1964-06

2.  ACTION OF RILEY'S PLASMA ENZYME-ELEVATING VIRUS IN MICE.

Authors:  B W MAHY
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

3.  A transmissible spleen weight increase factor (SWIF) of mice.

Authors:  P G STANSLY; D S RAMSEY; C F NEILSON
Journal:  Proc Soc Exp Biol Med       Date:  1962-02

4.  Frozen spleen reimplanted and challenged with Bartonella.

Authors:  W H CROSBY; N R BENJAMIN
Journal:  Am J Pathol       Date:  1961-07       Impact factor: 4.307

5.  The response of mice to large intravenous injections of ectromelia virus. I. The fate of injected virus.

Authors:  C A MIMS
Journal:  Br J Exp Pathol       Date:  1959-12

6.  A hepatitis virus of mice.

Authors:  A W GLEDHILL; C H ANDREWES
Journal:  Br J Exp Pathol       Date:  1951-12

7.  The mechanism of transmission of Haemobartonella muris (Mayer) of rats by the spined rat louse, Polyplax spinulosa (Burmeister).

Authors:  M M CRYSTAL
Journal:  J Parasitol       Date:  1958-12       Impact factor: 1.276

8.  SYNERGISM BETWEEN A LACTATE DEHYDROGENASE-ELEVATING VIRUS AND EPERYTHROZOON COCCOIDES.

Authors:  V RILEY
Journal:  Science       Date:  1964-11-13       Impact factor: 47.728

9.  HISTOPATHOGENESIS OF MOUSEPOX: III. ECTROMELIA VIRULENCE.

Authors:  J A ROBERTS
Journal:  Br J Exp Pathol       Date:  1963-10

10.  Enhancement of the pathogenicity of mouse hepatitis virus (MHVI) by prior infection of mice with certain leukaemia agents.

Authors:  A W GLEDHILL
Journal:  Br J Cancer       Date:  1961-09       Impact factor: 7.640

View more
  6 in total

1.  Prevalence and diagnosis of hemotrophic mycoplasma infection in research sheep and its effects on hematology variables and erythrocyte membrane fragility.

Authors:  Joseph A Hampel; Samantha N Spath; Ingrid L Bergin; Ailam Lim; Steven R Bolin; Melissa C Dyson
Journal:  Comp Med       Date:  2014-12       Impact factor: 0.982

2.  Haemolytic anaemia in the Gunn rat following transplantation of isolated hepatocytes injected with Haemobartonella muris.

Authors:  R J Woods; S P Parbhoo
Journal:  Br J Exp Pathol       Date:  1981-02

3.  RNA-Seq based transcriptome of whole blood from immunocompetent pigs (Sus scrofa) experimentally infected with Mycoplasma suis strain Illinois.

Authors:  Naíla C do Nascimento; Ana M S Guimaraes; Andrea P Dos Santos; Yuefeng Chu; Lucas M Marques; Joanne B Messick
Journal:  Vet Res       Date:  2018-06-18       Impact factor: 3.683

Review 4.  Immunodeficiencies caused by infectious diseases.

Authors:  Jane E Sykes
Journal:  Vet Clin North Am Small Anim Pract       Date:  2010-05       Impact factor: 2.093

5.  Occurrence and identification of hemotropic mycoplasmas (Hemoplasmas) in free ranging and laboratory rats (Rattus norvegicus) from two Brazilian zoos.

Authors:  Francisco de Oliveira Conrado; Naíla Cannes do Nascimento; Andrea Pires dos Santos; Cristina Kraemer Zimpel; Joanne Belle Messick; Alexander Welker Biondo
Journal:  BMC Vet Res       Date:  2015-11-23       Impact factor: 2.741

Review 6.  Review of clinical aspects, epidemiology and diagnosis of haemotropic Mycoplasma ovis in small ruminants: current status and future perspectives in tropics focusing on Malaysia.

Authors:  Bura Thlama Paul; Faez Firdaus Abdullah Jesse; Eric Lim Teik Chung; Azlan Che-Amat; Mohd Azmi Mohd Lila; Hamza Abdirahman Hashi; Mohd Jefri Norsidin
Journal:  Trop Anim Health Prod       Date:  2020-07-26       Impact factor: 1.559

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.